IP Library Granted Patent US 7,671,191
Granted Patent B2
US 7,671,191 · App. 11/975,080 · Granted Mar 2, 2010

Methods for preparing 2-alkynyladenosine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,671,191
App. No.
11/975,080
Granted
Mar 2, 2010
Kind
B2
Abstract

Disclosed are methods for preparing 2-alkynyladenosine derivatives of formula A: or a stereoisomer, pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate or isomorphic crystalline form thereof, the method comprising the step of: contacting 2-iodoadenosine-5′-N-ethyluronamide with a compound of formula B: wherein Z is —C(═O)OR or —CH 2 C(═O)R, where R is a C 1 to C 5 alkyl, preferably The methods are useful for preparing 2-alkynyladenosine derivatives that are, in certain embodiments, adenosine receptor agonists.

Claims (20)

1. A method for preparing a compound of formula A:

or a stereoisomer, pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate or isomorphic crystalline form thereof, the method comprising the step of:

(1) providing 2-iodoadenosine;

(2) protecting the hydroxyl groups of said 2-iodoadenosine with an acetonide group;

(3) oxidizing, via radical oxidation, the primary alcohol of said acetonide-protected 2-iodoadenosine to an acid derivative of said acetonide-protected 2-iodoadenosine;

(4) converting said acid derivative to an N-ethylamide derivative of said acetonide-protected 2-iodoadenosine;

(5) deprotecting said N-ethylamide of said acetonide-protected 2-iodoadenosine to form said 2-iodoadenosine-5′-N-ethyluronamide; and

(6) contacting said 2-iodoadenosine-5′-N-ethyluronamide with a compound of formula B in the presence of CuI and Pd(PPh 3 ) 2 Cl 2 :

wherein

Z is —C(═O)OR, where R is a C 1 to C 5 alkyl.

2. The method according to claim 1 , wherein Z is —C(═O)OCH 3 .

3. The method according to claim 1 , wherein said oxidizing step comprises the use of a mixture comprising bis-acetoxyiodobenzene and 2,2,6,6-tetramethyl piperidinyloxy free radical (TEMPO).

4. The method according to claim 1 , wherein said compound of formula B is prepared from 1,4-methanol cyclohexane.

5. The method according to claim 4 , wherein said 1,4-methanol cyclohexane is prepared from a reaction mixture comprising trans-1,4-dimethyl -cyclohexanedicarboxylate.

6. The method according to claim 5 , wherein said reaction mixture comprises less than about 0.2% by weight, based on the total weight of the 1,4-dimethyl-cyclohexanedicarboxylate, of cis-1,4-dimethyl-cyclohexanedicarboxylate.

7. The method according to claim 4 , wherein said 1,4-methanol cyclohexane is prepared by a process comprising the step of reducing 1,4-dimethyl -cyclohexanedicarboxylate.

8. The method according to claim 4 , further comprising the step of preparing the mono-tosyl derivative of said 1,4-methanol cyclohexane.

9. The method according to claim 8 , further comprising the step of acetylide substitution of said tosyl derivative of the formula:

to form and acetylide-substituted compound of the formula:

10. The method according to claim 9 , further comprising the steps of oxidizing said acetylide-substituted compound and esterifying said product of said oxidation to a compound of formula B, where Z is —C(═O)OR.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2013
From: DOGWOOD PHARMACEUTICALS, INC.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 029785/0460 →
MERGER Recorded Jan 9, 2012
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 027499/0121 →
MERGER Recorded Jan 9, 2012
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 027499/0196 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2012
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 027499/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2012
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 027499/0300 →
CHANGE OF NAME Recorded Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025709/0994 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2009
From: ADENOSINE THERAPEUTICS, LLC
To: PGXHEALTH, LLC
Reel/Frame 022075/0734 →